Cell and Gene Therapies: Live at Phacilitate with Joel Eichmann, CEO, Green Elephant
February 29, 2024
Discussing the trends in cell and gene therapeutics, with Joel Eichmann, CEO, Green Elephant, live at Phacilitate
1 min read

February 29, 2024
Discussing the trends in cell and gene therapeutics, with Joel Eichmann, CEO, Green Elephant, live at Phacilitate
1 min read
February 28, 2024
The world’s first clinical trial for a Hunter syndrome gene therapy opens in Manchester
5 min read
February 27, 2024
Meet Brad Hocking – a final year PhD student at Imperial College London who is passionate about small molecule drug discovery. Hocking is working under the joint supervision of David Mann and Alan Armstrong on projects in covalent fragment based drug discovery. Here, he discusses his work and what inspired his interest in this field.
6 min read
February 26, 2024
And how it can be explained with a parable of three farmers…
6 min read
February 22, 2024
Researchers have developed a new chemical entity that can cut alcohol consumption in half
4 min read
February 20, 2024
Researchers repurpose α-difluoromethylornithine as oral medication for type 1 diabetes
2 min read
February 19, 2024
We speak with Suzanne Diercksen, Head of Early and Emerging Talent at Vertex Pharmaceuticals, to learn about the opportunities that could lead to a career in biotech – from internships to co-ops and more.
12 min read
February 19, 2024
Janet Hemingway and Shaun Pennington of the iiCON consortium led by LSTM discuss their mission to find new treatments for infectious STIs
6 min read
February 15, 2024
Gene therapy approvals have come thick and fast in 2023. Now let’s talk about how we can ramp up manufacturing speed with platform processes
8 min read
February 14, 2024
Experts consider how decentralized clinical trials will change in the future
4 min read
False
False